1 |
-
Gut-liver axis in sepsis-associated liver injury: Epidemiology, challenges and clinical practice
-
12/9/2024 10:40:08 AM | Browse: 80 | Download: 333
|
2 |
-
Dysbiosis and colonic adenoma: The lethal link?
-
9/29/2024 6:08:21 AM | Browse: 106 | Download: 405
|
3 |
-
Microbiome as an endocrine organ and its relationship with eye diseases: Effective factors and new targeted approaches
-
9/20/2024 9:35:25 AM | Browse: 96 | Download: 430
|
4 |
-
Dysbiosis promotes recurrence of adenomatous polyps in the distal colorectum
-
8/8/2024 4:58:17 AM | Browse: 99 | Download: 657
|
5 |
-
Presepsin as a biomarker of bacterial translocation and an indicator for the prescription of probiotics in cirrhosis
-
5/22/2024 11:33:24 AM | Browse: 136 | Download: 565
|
6 |
-
Immunological mechanisms of fecal microbiota transplantation in recurrent Clostridioides difficile infection
-
8/31/2022 11:27:51 AM | Browse: 438 | Download: 1126
|
7 |
-
Impact of microbiota-immunity axis in pancreatic cancer management
-
8/26/2022 7:50:06 AM | Browse: 534 | Download: 1435
|
8 |
-
Gut microbiota, inflammatory bowel disease and colorectal cancer
-
8/10/2022 8:23:14 AM | Browse: 593 | Download: 1430
|
9 |
-
Gut microbiota and COVID-19: An intriguing pediatric perspective
-
8/1/2022 9:20:53 AM | Browse: 491 | Download: 1075
|
10 |
-
Gut microbiota interactions with anti-diabetic medications and pathogenesis of type 2 diabetes mellitus
-
7/20/2022 7:37:19 AM | Browse: 507 | Download: 1010
|
11 |
-
Gut microbiome dysbiosis in the setting of solid organ transplantation: What we have gleaned from human and animal studies
-
7/15/2022 3:59:33 AM | Browse: 473 | Download: 961
|
12 |
-
Gut dysbiosis and body composition in cirrhosis
-
6/23/2022 2:39:01 PM | Browse: 530 | Download: 2055
|
13 |
-
Gut microbiota in various childhood disorders: Implication and indications
-
5/12/2022 8:42:29 AM | Browse: 485 | Download: 1044
|
14 |
-
Helicobacter pylori, gastric microbiota and gastric cancer relationship: Unrolling the tangle
-
5/10/2022 9:43:36 AM | Browse: 420 | Download: 1027
|
15 |
-
Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice
-
4/29/2022 6:42:52 AM | Browse: 604 | Download: 2125
|
16 |
-
Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis
-
3/11/2022 9:47:59 AM | Browse: 557 | Download: 1883
|
17 |
-
“Role of exercise in preventing and restoring gut dysbiosis in patients with inflammatory bowel disease”: A letter to the editor
-
2/24/2022 9:46:00 AM | Browse: 554 | Download: 984
|
18 |
-
Gastrointestinal microbiome and Helicobacter pylori: Eradicate, leave it as it is, or take a personalized benefit–risk approach?
-
2/17/2022 9:46:13 AM | Browse: 608 | Download: 1367
|
19 |
-
COVID-19 and gut immunomodulation
-
12/10/2021 9:08:48 AM | Browse: 601 | Download: 1168
|
20 |
-
COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms
-
11/19/2021 11:15:33 AM | Browse: 653 | Download: 1624
|
21 |
-
Gossip in the gut: Quorum sensing, a new player in the host-microbiota interactions
-
11/10/2021 7:13:09 AM | Browse: 605 | Download: 1369
|
22 |
-
Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases
-
9/29/2021 11:12:00 AM | Browse: 633 | Download: 1451
|
23 |
-
Characterization of gut microbiome and metabolome in Helicobacter pylori patients in an underprivileged community in the United States
-
9/3/2021 11:45:55 AM | Browse: 630 | Download: 1908
|
24 |
-
Gut microbiome in acute pancreatitis: A review based on current literature
-
8/10/2021 6:48:42 AM | Browse: 648 | Download: 1338
|
25 |
-
Gastrectomy impact on the gut microbiome in patients with gastric cancer: A comprehensive review
-
7/23/2021 6:56:53 AM | Browse: 660 | Download: 1670
|
26 |
-
Looking into the key bacterial proteins involved in gut dysbiosis
-
7/19/2021 4:30:58 AM | Browse: 603 | Download: 1510
|
27 |
-
Gut microbiota in obesity
-
7/6/2021 2:31:17 AM | Browse: 669 | Download: 1747
|
28 |
-
Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
-
6/18/2021 5:06:16 AM | Browse: 751 | Download: 1812
|
29 |
-
Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis
-
5/20/2021 3:14:20 PM | Browse: 754 | Download: 2238
|
30 |
-
Gut microbiota dysbiosis in Chinese children with type 1 diabetes mellitus: An observational study
-
5/13/2021 10:05:39 AM | Browse: 673 | Download: 2136
|
31 |
-
Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome
-
5/10/2021 7:46:10 AM | Browse: 784 | Download: 2204
|
32 |
-
Role of microbial dysbiosis in the pathogenesis of esophageal mucosal disease: A paradigm shift from acid to bacteria?
-
5/10/2021 7:46:10 AM | Browse: 731 | Download: 1657
|
33 |
-
Paediatric gastrointestinal disorders in SARS-CoV-2 infection: Epidemiological and clinical implications
-
4/21/2021 5:56:26 AM | Browse: 750 | Download: 1630
|
34 |
-
COVID-19 and gastrointestinal tract: Source of infection or merely target of the inflammatory process following SARS-CoV-2 infection?
-
4/9/2021 9:07:56 AM | Browse: 622 | Download: 1309
|
35 |
-
Oral microbiome and pancreatic cancer
-
12/25/2020 10:20:16 AM | Browse: 821 | Download: 2431
|
36 |
-
Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome
-
12/4/2020 6:04:55 AM | Browse: 831 | Download: 2497
|
37 |
-
Vaccine therapy for dysbiosis-related diseases
-
6/6/2020 2:43:56 PM | Browse: 1042 | Download: 2036
|
38 |
-
Role of gut microbiota in cardiovascular diseases
-
4/22/2020 1:22:08 PM | Browse: 1026 | Download: 1545
|
39 |
-
Characterization of microbiota in systemic-onset juvenile idiopathic arthritis with different disease severities
-
9/24/2019 9:22:56 AM | Browse: 888 | Download: 2226
|
40 |
-
Healthy axis: Towards an integrated view of the gut-brain health
-
8/7/2019 7:09:17 AM | Browse: 1020 | Download: 1891
|
41 |
-
Mucosal healing progression after acute colitis in mice
-
7/19/2019 12:39:13 PM | Browse: 977 | Download: 2221
|
42 |
-
Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified
-
6/14/2019 9:34:50 AM | Browse: 1377 | Download: 2111
|
43 |
-
Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma
-
5/14/2019 7:58:39 AM | Browse: 977 | Download: 1980
|
44 |
-
Modulation of faecal metagenome in Crohn’s disease: Role of microRNAs as biomarkers
-
12/13/2018 6:32:35 AM | Browse: 1062 | Download: 1957
|
45 |
-
Clinical impact of microbiome in patients with decompensated cirrhosis
-
9/14/2018 5:53:04 AM | Browse: 1148 | Download: 2039
|
46 |
-
Microbial markers in colorectal cancer detection and/or prognosis
-
6/11/2018 1:12:19 AM | Browse: 1394 | Download: 1841
|
47 |
-
Fecal microbiota transplantation against irritable bowel syndrome? Rigorous randomized clinical trials are required
-
11/1/2017 9:02:15 AM | Browse: 1202 | Download: 1942
|
48 |
-
Influence of gut microbiota on neuropsychiatric disorders
-
8/14/2017 8:57:06 AM | Browse: 1364 | Download: 2695
|
49 |
-
Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis
-
7/7/2017 11:41:16 AM | Browse: 1581 | Download: 3602
|
50 |
-
Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation
-
7/7/2017 11:41:16 AM | Browse: 1279 | Download: 2051
|